MARSHALL WACE, LLP - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 145 filers reported holding ASSERTIO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$613,000
-75.2%
942,564
-52.3%
0.01%
-64.7%
Q4 2019$2,470,000
+399.0%
1,976,052
+1276.7%
0.02%
+325.0%
Q2 2019$495,000
-93.8%
143,538
-90.9%
0.00%
-89.5%
Q1 2019$7,956,000
+459.9%
1,569,146
+298.8%
0.04%
+153.3%
Q4 2018$1,421,000393,4960.02%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 127,850$164,0000.08%
PERKINS CAPITAL MANAGEMENT INC 69,600$89,0000.08%
GLOBEFLEX CAPITAL L P 213,991$274,0000.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,500,000$1,920,000,0000.05%
DELTEC ASSET MANAGEMENT LLC 162,700$208,0000.05%
Spark Investment Management LLC 285,588$365,0000.05%
Factorial Partners, LLC 37,000$47,360,0000.04%
HighVista Strategies LLC 43,400$56,0000.04%
OAKTREE CAPITAL MANAGEMENT LP 1,492,455$1,910,0000.04%
OXFORD ASSET MANAGEMENT LLP 1,036,375$1,327,0000.03%
View complete list of ASSERTIO THERAPEUTICS INC shareholders